Junfei Zhu

机构：Taizhou Central Hospital, Taizhou University · ORCID：0000-0003-2345-7321

发表论文 68 篇 · 总被引 1428 次 · h-index 20

代表论文

• Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial (2024 · Signal Transduction and Targeted Therapy · 被引 36)
• The application of nanopore targeted sequencing for pathogen diagnosis in bronchoalveolar lavage fluid of patients with pneumonia: a prospective multicenter study (2023 · Scandinavian Journal of Infectious Diseases · 被引 31)
• Application of exosomes as nanocarriers in cancer therapy (2023 · Journal of Materials Chemistry B · 被引 16)
• Cuproptosis in cancer therapy: mechanisms, therapeutic application and future prospects (2024 · Journal of Materials Chemistry B · 被引 12)
• Characterization and anticancer effects of extracellular polysaccharide from DHA-producing microalga Crypthecodinium sp. SUN (2023 · International Journal of Biological Macromolecules · 被引 11)
• High-Dose Aumolertinib for Untreated EGFR -Variant Non–Small Cell Lung Cancer With Brain Metastases (2025 · JAMA Oncology · 被引 10)